Publicly available records indicate that a class action lawsuit has been filed on behalf of investors in Obalon Therapeutics (NASDAQ: OBLN) in connection to alleged violations of securities laws by OBLN. Fitapelli Kurta is interested in speaking to investors who have complaints regarding investments made in Obalon Therapeutics from October 2, 2016 until January 23,…

Read More